Eisai Co Ltd
TSE:4523

Watchlist Manager
Eisai Co Ltd Logo
Eisai Co Ltd
TSE:4523
Watchlist
Price: 4 689 JPY 0.34%
Market Cap: 1.4T JPY

Relative Value

The Relative Value of one Eisai Co Ltd stock under the Base Case scenario is hidden JPY. Compared to the current market price of 4 689 JPY, Eisai Co Ltd is hidden .

Relative Value is the estimated value of a stock based on various valuation multiples like P/E and EV/EBIT ratios. It offers a quick snapshot of a stock's valuation in relation to its peers and historical norms.

Eisai Co Ltd Relative Value
HIDDEN
Show
Worst Case
Base Case
Best Case

Valuation Multiples

vs History
85
vs Industry
60
Median 3Y
2.4
Median 5Y
2.6
Industry
2.6
Forward
1.6
vs History
74
vs Industry
23
Median 3Y
41.2
Median 5Y
39.3
Industry
21.7
Forward
26.7
vs History
65
vs Industry
7
Median 3Y
47
Median 5Y
32.1
Industry
16.6
vs History
80
vs Industry
17
Median 3Y
33.7
Median 5Y
33
Industry
22.5
vs History
84
vs Industry
51
Median 3Y
2.1
Median 5Y
2.4
Industry
2.3
vs History
82
vs Industry
65
Median 3Y
2.2
Median 5Y
2.4
Industry
2.9
Forward
1.4
vs History
82
vs Industry
75
Median 3Y
2.8
Median 5Y
3
Industry
5.5
vs History
87
vs Industry
35
Median 3Y
18.2
Median 5Y
18.2
Industry
13.1
Forward
11.7
vs History
69
vs Industry
29
Median 3Y
24.8
Median 5Y
25.4
Industry
16.6
Forward
16.2
vs History
65
vs Industry
8
Median 3Y
41.6
Median 5Y
28.6
Industry
15.8
vs History
49
vs Industry
1
Median 3Y
54.8
Median 5Y
46.1
Industry
19.1
vs History
82
vs Industry
59
Median 3Y
1.7
Median 5Y
1.9
Industry
1.9

Multiples Across Competitors

Competitors Multiples
Eisai Co Ltd Competitors

All Multiples
P/S
P/E
EV/EBITDA
EV/EBIT
All Countries
Close
Market Cap P/S P/E EV/EBITDA EV/EBIT
JP
Eisai Co Ltd
TSE:4523
1.3T JPY 1.6 26.8 11.5 19
US
Eli Lilly and Co
NYSE:LLY
929B USD 15.6 50.5 33.9 36.4
UK
Dechra Pharmaceuticals PLC
LSE:DPH
440.4B GBP 578.3 -15 783.5 3 846.3 17 702.3
US
Johnson & Johnson
NYSE:JNJ
481.1B USD 5.2 19.2 15.7 20.4
CH
Roche Holding AG
SIX:ROG
249.4B CHF 4 26.5 11.3 13.2
UK
AstraZeneca PLC
LSE:AZN
210.1B GBP 4.8 29.7 108 158.1
CH
Novartis AG
SIX:NOVN
203.5B CHF 4.5 17.5 11.1 14.4
US
Merck & Co Inc
NYSE:MRK
241B USD 3.8 12.7 9.1 10.7
DK
Novo Nordisk A/S
CSE:NOVO B
1.3T DKK 4.2 12.9 9 10.5
IE
Endo International PLC
LSE:0Y5F
202.5B USD 87.3 -69.3 321.2 805.4
US
Pfizer Inc
NYSE:PFE
144B USD 2.3 14.7 7.5 10.2
P/E Multiple
Earnings Growth PEG
JP
Eisai Co Ltd
TSE:4523
Average P/E: 23.4
26.8
14%
1.9
US
Eli Lilly and Co
NYSE:LLY
50.5
53%
1
UK
Dechra Pharmaceuticals PLC
LSE:DPH
Negative Multiple: -15 783.5 N/A N/A
US
Johnson & Johnson
NYSE:JNJ
19.2
29%
0.7
CH
Roche Holding AG
SIX:ROG
26.5
29%
0.9
UK
AstraZeneca PLC
LSE:AZN
29.7
38%
0.8
CH
Novartis AG
SIX:NOVN
17.5
17%
1
US
Merck & Co Inc
NYSE:MRK
12.7
15%
0.8
DK
Novo Nordisk A/S
CSE:NOVO B
12.9
4%
3.2
IE
E
Endo International PLC
LSE:0Y5F
Negative Multiple: -69.3 N/A N/A
US
Pfizer Inc
NYSE:PFE
14.7
29%
0.5
EV/EBITDA Multiple
EBITDA Growth EV/EBITDA to Growth
JP
Eisai Co Ltd
TSE:4523
Average EV/EBITDA: 398.6
11.5
12%
1
US
Eli Lilly and Co
NYSE:LLY
33.9
33%
1
UK
Dechra Pharmaceuticals PLC
LSE:DPH
3 846.3
36%
106.8
US
Johnson & Johnson
NYSE:JNJ
15.7
9%
1.7
CH
Roche Holding AG
SIX:ROG
11.3
4%
2.8
UK
AstraZeneca PLC
LSE:AZN
108
10%
10.8
CH
Novartis AG
SIX:NOVN
11.1
6%
1.9
US
Merck & Co Inc
NYSE:MRK
9.1
6%
1.5
DK
Novo Nordisk A/S
CSE:NOVO B
9
2%
4.5
IE
E
Endo International PLC
LSE:0Y5F
321.2
N/A N/A
US
Pfizer Inc
NYSE:PFE
7.5
1%
7.5
EV/EBIT Multiple
EBIT Growth EV/EBIT to Growth
JP
Eisai Co Ltd
TSE:4523
Average EV/EBIT: 1 709.1
19
N/A N/A
US
Eli Lilly and Co
NYSE:LLY
36.4
36%
1
UK
Dechra Pharmaceuticals PLC
LSE:DPH
17 702.3
98%
180.6
US
Johnson & Johnson
NYSE:JNJ
20.4
15%
1.4
CH
Roche Holding AG
SIX:ROG
13.2
5%
2.6
UK
AstraZeneca PLC
LSE:AZN
158.1
23%
6.9
CH
Novartis AG
SIX:NOVN
14.4
12%
1.2
US
Merck & Co Inc
NYSE:MRK
10.7
8%
1.3
DK
Novo Nordisk A/S
CSE:NOVO B
10.5
1%
10.5
IE
E
Endo International PLC
LSE:0Y5F
805.4
N/A N/A
US
Pfizer Inc
NYSE:PFE
10.2
8%
1.3